This post was originally published on this site
Bristol-Myers Squibb announced earnings per share of $1.93 on revenue of $11.89B. Analysts polled by Investing.com anticipated EPS of $1.8 on revenue of $11.44B.
Bristol-Myers Squibb shares are down 10% from the beginning of the year, still down 8.64% from its 52 week high of $80.59 set on June 27. They are outperforming the S&P 500 which is down 17.73% from the start of the year.
Bristol-Myers Squibb’s report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
